Profile
Currently, Jon Ellis holds the position of Vice President & Head-Science & Technology at GlaxoSmithKline Plc. He is also on the board of Orchard Therapeutics (Europe) Ltd. and Orchard Therapeutics Plc. Dr. Ellis received a doctorate from the University of Cambridge, an MBA from Henley Management College and an undergraduate degree and a graduate degree from Magdalene College.
Jon Ellis active positions
| Companies | Position | Start |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Director/Board Member | 2018-08-01 |
Former positions of Jon Ellis
| Companies | Position | End |
|---|---|---|
| GSK PLC | Chief Tech/Sci/R&D Officer | 2022-07-31 |
| ORCHARD THERAPEUTICS PLC | Director/Board Member | 2021-06-15 |
Training of Jon Ellis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henley Management College
Henley Management College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magdalene College
Magdalene College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
- Stock Market
- Insiders
- Jon Ellis
















